The following was posted by FLEXNP on bluesky social along with these pics.
“Things that make me go
Long acting GIP agonist given to humans for 12 weeks resulted in a significant increase in insulin sensitivity (~33%) vs GLP-1 agonist. Combine the two and the effect mirrors GIP alone. Makes one wonder why there aren't more dual GLP 1/GIP agonists in development!”
“Things that make me go
Long acting GIP agonist given to humans for 12 weeks resulted in a significant increase in insulin sensitivity (~33%) vs GLP-1 agonist. Combine the two and the effect mirrors GIP alone. Makes one wonder why there aren't more dual GLP 1/GIP agonists in development!”
